Oncodesign Services

Oncodesign Services extends collaboration with GIP ARRONAX to strengthen astatine-211 supply for targeted alpha radiotherapy

13 April 2026 -- Dijon, France -- Oncodesign Services has extended its collaboration with GIP ARRONAX to secure access to astatine-211 (At-211) as well as other radionuclides used in targeted radiotherapy (TRT), supporting the advancement of discovery and preclinical programs. The collaboration builds on an existing relationship between the two organizations and focuses on securing...
20 Rue Jean Mazen 21 000 Dijon France

+33 3 80 78 82 60